Evidence map›Paper›PMID 25188838›Full record

ArticleJournal of the American Chemical Society2014

Engineering bacterial transcription regulation to create a synthetic in vitro two-hybrid system for protein interaction assays.

Ying Zhou, Haruichi Asahara, Nils Schneider, Patricia Dranchak, James Inglese, Shaorong Chong

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Ying ZhouNew England Biolabs, Inc. 240 County Road, Ipswich, Massachusetts 01938, United States.
Haruichi Asahara
Nils Schneider
Patricia Dranchak
James Inglese
Shaorong Chong
University of Freiburg · DENational Center for Advancing Translational Sciences · USÉcole Supérieure de Biotechnologie de Strasbourg · FR

Funding

Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead DiscoveryZIATR000053 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI INGLESE, JAMES · 2015 to 2025
$4.5M
In vitro Reconstitution of Protein Translation of Thermus Thermophilus for DirectR44GM086930 · NIGMS · NEW ENGLAND BIOLABS, INC. · PI CHONG, SHAORONG · 2012 to 2013
$960k
In vitro Reconstitution of Protein Translation of Thermus Thermophilus for DirectR43GM086930 · NIGMS · NEW ENGLAND BIOLABS, INC. · PI CHONG, SHAORONG, ZHENG, YU · 2009 to 2009
$233k
Intramural NIH HHSNIGMS NIH HHS GM086930NIGMS NIH HHS R43 GM086930NIGMS NIH HHS R44 GM086930
6 · The paper itself

Abstract

Transcriptional activation of σ(54)-RNA polymerase holoenzyme (σ(54)-RNAP) in bacteria is dependent on a cis-acting DNA element (bacterial enhancer), which recruits the bacterial enhancer-binding protein to contact the holoenzyme via DNA looping. Using a constructive synthetic biology approach, we recapitulated such process of transcriptional activation by recruitment in a reconstituted cell-free system, assembled entirely from a defined number of purified components. We further engineered the bacterial enhancer-binding protein PspF to create an in vitro two-hybrid system (IVT2H), capable of carrying out gene regulation in response to expressed protein interactions. Compared with genetic systems and other in vitro methods, IVT2H not only allows detection of different types of protein interactions in just a few hours without involving cells but also provides a general correlation of the relative binding strength of the protein interaction with the IVT2H signal. Due to its reconstituted nature, IVT2H provides a biochemical assay platform with a clean and defined background. We demonstrated the proof-of-concept of using IVT2H as an alternative assay for high throughput screening of small-molecule inhibitors of protein-protein interaction.

Indexed as

Gene Expression Regulation, BacterialTranscription, GeneticTwo-Hybrid System TechniquesCell-Free SystemDNADNA-Directed RNA PolymerasesDrug Evaluation, PreclinicalEarly Growth Response Protein 1Escherichia coliGenes, ReporterGenetic EngineeringHigh-Throughput Screening AssaysRNASmall Molecule LibrariesViral ProteinsDNADNA-Directed RNA PolymerasesEarly Growth Response Protein 1RNASmall Molecule LibrariesViral Proteins

Identifiers

PMID25188838
PMCPMC4195380
OpenAlexW2467580774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.